Abstract
This article summarizes the clinical aspects, cytogenetics, and initiating agents associated with therapy-related myelodysplastic syndromes. Details regarding associated chemotherapeutic agents and ionizing radiation are discussed and therapeutic considerations are presented.
Publication types
-
Research Support, Non-U.S. Gov't
-
Research Support, U.S. Gov't, P.H.S.
-
Review
MeSH terms
-
Antineoplastic Agents / adverse effects*
-
Humans
-
Myelodysplastic Syndromes / chemically induced
-
Myelodysplastic Syndromes / etiology*
-
Myelodysplastic Syndromes / genetics
-
Radiotherapy / adverse effects*
-
Risk Factors